IDH2 mutation associated with favourable outcome in older adults with newly diagnosed ALL treated with lower-intensity therapy

Overview of cancer health disparities: Current state and future directions

Bladder cancer updates from the second half of 2024

Understanding cognitive impairment for elderly patients undergoing CAR T therapy

CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC

Fracture risk increases following cancer therapies for advanced prostate cancer

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study

Geriatric interventions are beneficial in reducing treatment-related toxicity in older adults with cancer

Understanding the remaining unmet needs in a post ASCT NDMM setting

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

ESMO and WCLC: Latest developments in EGFR mutated NSCLC

Multiple Myeloma: evolving paradigm - Panel Discussion